Under the guidelines established by the European REACh Directive, all chemical substances are subject to strict regulations aimed at safeguarding human and environmental safety.

The Registration, Evaluation, Authorization, and Restriction of Chemicals (REACh) Regulation was enacted by the European Union (EU) in June 2007, replacing previous legislation regulating chemicals in the EU market.  Fundamentally, the goal of REACh is to provide a single, consistent legislative system for new and existing chemicals.

The core objectives of REACh

Beginning June 2008, all new and "phase-in" substances manufactured or imported in volumes greater than one ton per year must be registered with the European Chemicals Agency (ECHA) in Helsinki, Finland.  "Phase-in" substances are defined as existing chemicals with insufficient or no safety data.

The core objectives of REACh include:

  • Protection of human health and the environment safety
  • Promotion of the 3Rs principle
  • Maintenance of competitiveness of the EU Chemical Industry
  • Enhancement of innovative capability of EU Chemical Industry

REACh Products & Services from Invitrogen

As an in industry leader with over 48,000 years of toxicity testing experience, Invitrogen has developed a robust portfolio of In Vitro Safety Assessment Testing Products and Services designed to facilitate compliance and reduce the need for animal testing.  Invitrogen offers a comprehensive range of consultative services developed by industry leaders in collaboration with key regulatory bodies.

For Research Use Only. Not for use in diagnostic procedures.